Page last updated: 2024-08-16

zm 336372 and az-628

zm 336372 has been researched along with az-628 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali, S; Burke, R; Cheeseman, MD; Chessum, NE; De Billy, E; Eccles, SA; Evans, LE; Hayes, A; Henley, AT; Jones, K; Lepri, S; Miah, A; O'Fee, L; Pasqua, AE; Pellegrino, L; Powers, M; Raynaud, F; Richards, M; Rowlands, M; Rye, CS; Sharp, SY; Te Poele, R; Tucker, MJ; van Montfort, RL; Wilding, B; Workman, P	1

Other Studies

1 other study(ies) available for zm 336372 and az-628

Article	Year
Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen. Journal of medicinal chemistry, 2017, 01-12, Volume: 60, Issue:1 Topics: Administration, Oral; Amides; Biological Availability; Carbon-13 Magnetic Resonance Spectroscopy; Carrier Proteins; Dioxygenases; DNA-Binding Proteins; Drug Discovery; Heat Shock Transcription Factors; Ligands; Nuclear Proteins; Proton Magnetic Resonance Spectroscopy; Quinolines; Spectrometry, Mass, Electrospray Ionization; Transcription Factors	2017

Article

Year

Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen.

Journal of medicinal chemistry, 2017, 01-12, Volume: 60, Issue:1

Topics: Administration, Oral; Amides; Biological Availability; Carbon-13 Magnetic Resonance Spectroscopy; Carrier Proteins; Dioxygenases; DNA-Binding Proteins; Drug Discovery; Heat Shock Transcription Factors; Ligands; Nuclear Proteins; Proton Magnetic Resonance Spectroscopy; Quinolines; Spectrometry, Mass, Electrospray Ionization; Transcription Factors

2017